2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Hyperthermia
22
Sarcoma
8
Uterine Cervical Neoplasms
7
Breast Neoplasms
6
Rectal Neoplasms
5
Prostatic Neoplasms
5
Ovarian Neoplasms
5
Colonic Neoplasms
5
Neoplasms
4
Neoplasm Metastasis
4
Head and Neck Neoplasms
4
Urinary Bladder Neoplasms
3
Melanoma
3
Lung Neoplasms
3
Carcinoma, Hepatocellular
3
Sarcoma, Synovial
2
Neurofibrosarcoma
2
Liver Neoplasms
2
Liposarcoma
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Fibrosarcoma
2
Colorectal Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Unspecified Adult Solid Tumor, Protocol Specific
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Sarcoma, Clear Cell
1
Sarcoma, Alveolar Soft Part
1
Interventions
Metformin
2
nicotinamide-beta-riboside
1
Surveys and Questionnaires
1
Liraglutide
1
Interviews as Topic
1
Diathermy
1
Continuous Glucose Monitoring
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prediabetic State
×
Diathermy
×
Clear all
NCT03644524
2018-08-23
CMH
University of Oregon
Phase NA
Completed
20 enrolled